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Langerhans Cells Favor Skin Flora Tolerance through
Limited Presentation of Bacterial Antigens and
Induction of Regulatory T Cells
Angelic M.G. van der Aar1,2, Daisy I. Picavet2, Femke J. Muller1, Leonie de Boer3, Toni M.M. van Capel1,
Sebastian A.J. Zaat3, Jan D. Bos2, Hans Janssen4, Thaddeus C. George5, Martien L. Kapsenberg1,
S. Marieke van Ham6, Marcel B.M. Teunissen2,7 and Esther C. de Jong1,7
The mechanisms preventing detrimental T-cell responses against commensal skin bacteria remain elusive. Using
monocyte-derived and skin-derived dendritic cells (DCs), we demonstrate that epidermal Langerhans cells (LCs),
the DCs in the most superficial layer of the skin, have a poor capacity to internalize bacteria because of low
expression of FcgRIIa. Furthermore, LCs show deficiency in processing and major histocompatibility complex II
(MHC-II)-restricted presentation of bacterial antigens, as a result of a decreased expression of molecules involved
in these functionalities. The reduced capacity to take up, process, and present bacterial antigens cannot be
restored by LC activation by ectopically expressed Toll-like receptors or by cytokines. Consequently, bacteria-
primed LCs poorly restimulate antibacterial memory CD4þ T cells and inefficiently induce bacteria-specific
effector CD4þ T cells from naive T cells; however, they initiate the development of regulatory Foxp3þCD4þ
T cells, which are able to suppress the proliferation of autologous bystander T cells specific for the same bacteria.
In contrast, dermal DCs that reside in the deeper dermal layer of the skin efficiently present bacterial antigens
and provoke robust antibacterial naive and memory CD4þ T-cell responses. In conclusion, LCs form a unique DC
subset that is adapted at multiple levels for the maintenance of tolerance to bacterial skin flora.
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INTRODUCTION
An important function of dendritic cells (DCs) is induction of
antigen (Ag)-specific T-cell responses to control microbial
infections (Banchereau and Steinman, 1998; Kapsenberg,
2003). Upon detection of microbes, DCs upregulate major
histocompatibility complex (MHC) and costimulatory mole-
cules, produce inflammatory cytokines, and migrate to drain-
ing lymph nodes to activate T cells. CD4þ T-cell activation
depends on the capacity of DCs to present exogenous Ags on
MHC-II. To present Ags to activate CD4þ T cells, DCs interna-
lize and process microorganisms. During the process of inter-
nalization, microorganisms are encapsulated by the plasma
membrane forming an intracellular vacuole known as the
phagosome. The phagosome undergoes a series of regulated
fusion events with endocytic organelles, first with endosomes
and subsequently with lysosomes, modifying their composition
(Trombetta and Mellman, 2005; Burgdorf and Kurts, 2008).
During this process, internalized material is degraded into small
fragments and loaded onto MHC-II. The type and quality of
T-cell responses are additionally determined by costimulatory
and polarizing signals (Banchereau and Steinman, 1998;
Kapsenberg, 2003). Memory CD4þ T cells do not require exten-
sive costimulation and mainly depend on Ag presentation for
optimal activation, whereas Ag presentation to naive CD4þ
T cells in absence of costimulation may lead to T-cell anergy or
tolerance (Banchereau and Steinman, 1998; Steinman et al.,
2003; Iwasaki and Medzhitov, 2004).
In human skin, initiation of T-cell responses mainly
depends on two different DC subsets: Langerhans cells (LCs)
(Rowden et al., 1977; Teunissen et al., 2012), which form a
three-dimensional network in the epidermis, and interstitial
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dermal DCs (DDCs), which are solely found in the dermal
layer of the skin (Rowden et al., 1977; Nestle et al., 1998;
Teunissen et al., 2012). LCs do not express cell surface Toll-
like receptor TLR2, TLR4, and TLR5, and thus resulting in a
limited responsiveness of LCs to extracellular bacteria in terms
of upregulation of costimulatory molecules and production of
inflammatory cytokines. In marked contrast, DDCs do express
these TLRs and vigorously respond to bacteria (Takeuchi et al.,
2003; Flacher et al., 2006; van der Aar et al., 2007). It is
attractive to hypothesize that because LCs reside in close
contact with the bacterial skin flora, they have a limited
function in the initiation of antibacterial immunity to prevent
excessive inflammation, whereas DDCs are specialized in the
induction of antibacterial immunity. Furthermore, the question
remains whether, and by what mechanisms, LCs prevent
reactivation of bacteria-specific memory T cells that are
present in the skin. We show that LCs have a very low
capacity to internalize and process bacteria, resulting in a
limited MHC-II-mediated presentation of bacterial Ags. In
addition, bacteria-primed LCs can drive the development of
Foxp3þ regulatory CD4þ T cells. Thus, LCs possess several
intrinsic properties that prevent induction of strong, probably
unwanted, antibacterial CD4þ T-cell responses. We propose
that these unique properties of LCs render the epidermis into a
selective immune-privileged site to accommodate interaction
with the commensal bacterial skin flora, whereas the dermis,
with DDCs as bacteria-recognizing sentinels, forms the true
immunological barrier for the skin against penetrating bacteria.
RESULTS
LCs are weak activators of bacteria-specific CD4þ T cells and
induce bacteria-specific Foxp3þ T cells
To get insight into the role of LCs and DDCs in the induction
of antibacterial T-cell responses, we compared their ability to
stimulate naive autologous CD4þ T cells specific for Gram-
positive S. aureus or Gram-negative E. coli. Clearly, the
induction of naive T-cell proliferation by LCs was less
compared with the proliferation induced by DDCs at different
DC:T cell ratios (Figure 1a and Supplementary Figure S1a
online). This was in line with the expectations as bacteria
induce high levels of costimulatory and MHC-II molecule
expression by DDCs but not by LCs (Takeuchi et al., 2003;
Flacher et al., 2006; van der Aar et al., 2007). To obtain full
maturation of LCs, we added IL-1b/TNF-a (MF) together with
S. aureus (Supplementary Figure S1b online). This increased
their capacity to induce bacteria-specific T-cell proliferation,
however, not to the same extent as bacteria-loaded DDCs
(Figure 1b), demonstrating that additional factors, such as the
amount of presented bacterial Ags, have a role in the inferior
capacity of LCs to prime antibacterial CD4þ T cells. Remark-
ably, the T cells activated with S. aureus-primed or E. coli-
primed LCs contained a high percentage of Foxp3þCD127neg
cells, a phenotype associated with regulatory T cells (Tregs),
whereas this population was almost absent when DDCs were
used (Figure 1c and Supplementary Figure S1c online).
Addition of MF during bacteria loading of LCs abrogated the
formation of Foxp3þ T cells (Figure 1c and Supplementary
Figure S1c online).
To investigate whether the T cells primed by S. aureus-primed
LCs indeed acquired regulatory capacities, we tested their ability
to suppress the proliferation of activated bystander CD4þ
T cells. Indeed, the T cells promoted by S. aureus-primed LCs
were able to suppress the proliferation of autologous bystander
T cells, whereas the T cells promoted by S. aureus-primed
DDCs did not suppress the proliferation (Figure 1d), confirming
that the Foxp3þ T cells induced by S. aureus-primed LCs are
indeed regulatory T cells. In line with the absence of Foxp3þ
T cells, the presence of MF abrogated the suppressive capacity
of the LC-induced T cells. Moreover, inhibition of TGF-b
signaling by SMAD3 inhibitor, almost completely abrogated
development of Foxp3þ T cells (Figure 1e), showing an
essential role for TGF-b in the induction of these Tregs.
In contrast to naive T cells, effector T cells do not require
extensive costimulation and are mainly dependent on Ag
presentation. We investigated to what extent bacteria-loaded
LCs and DDCs induce the proliferation of autologous bacteria-
specific effector CD4þ T cells (Supplementary Figure S1d
online). S. aureus-loaded LCs consistently induced signifi-
cantly lower proliferation of S. aureus-specific T-cell lines
compared with DDCs at all bacteria:DC ratios and DC:T cell
ratios tested (Figure 1f and g). The same results were obtained
with E. coli (Supplementary Figure S1e and f online). Addition
of MF did not enhance the proliferation of bacteria-specific
T cells, confirming that lack of costimulation did not have a
role. Collectively, these data indicate that LCs are not only
inefficient in priming bacteria-specific naive T cells but also in
reactivating memory T cells.
LCs inefficiently internalize bacteria because of low CD32
expression
To investigate whether the low efficiency of LCs to activate
T cells is the result of a limited capacity to internalize
particulate Ag, we incubated LCs and DDCs with GFP-
expressing bacteria and quantified internalization by FACS
(Suplementary Figure S2a). LCs internalized significantly lower
amounts of S. aureus or E. coli compared with DDCs at all
bacteria:DC ratios tested. Not only was the percentage of LCs
that internalized bacteria lower than that of DDCs but also the
mean amount of bacteria taken up per cell was 3–6 times less
for LCs (Figure 2a and Supplementary Figure S2b and c
online). To verify the in vivo relevance of these findings, we
investigated bacterial uptake by skin-derived LCs and DDCs
and again observed the same differences (Figure 2b and
Supplementary Figure S2d and e online). The differences in
the bacterial uptake were confirmed by confocal laser scan-
ning microscopy (CLSM), electron microscopy (EM), and
multispectral imaging (Supplementary Figure S2f–h online).
No internalization was observed at 4 1C (data not shown),
indicating that active uptake of the bacteria was required for
internalization. Moreover, after a longer time period LCs did
not reach the same level of uptake of S. aureus as DDCs
(Supplementary Figure S2i and j online), showing that LCs did
not simply require more time to internalize the same number
of bacteria as DDCs.
EM analysis revealed that LCs regularly (B50% of the cases)
formed a phagocytic cup to internalize bacteria, whereas
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DDCs did not (Figure 3a), suggesting that LCs and DDCs use
different uptake mechanisms, but treatment with various
inhibitors showed that bacteria were internalized through a
clathrin-independent and caveolin-independent mechanism
requiring actin polymerization by both DC subsets
(Supplementary Figure S3a–c online). Lack of inhibition by
mannan showed that C-type lectins were also not involved
(Supplementary Figure S3d online). However, internalization
of bacteria was substantially reduced when human serum
was absent (Figure 3b), suggesting an important role for
complement receptors and/or FcRs. A major contribution by
complement was ruled out as heat inactivation did not affect
uptake (Supplementary Figure S3e online). Opsonization of S.
aureus with purified human Ig enhanced bacterial internaliza-
tion significantly, and blocking of FcRs reduced the bacterial
uptake by both DC subtypes to the level of serum-free
conditions (Figure 3b). Bacterial uptake by skin-derived and
in vitro–generated LCs and DDCs was significantly reduced by
blocking CD32 but not by blocking CD16 or CD64 (Figure 3c
and d). FACS analysis revealed a markedly lower expression of
FcRs by LCs than by DDCs (Figure 3e and f). Collectively,
these data indicate that the differences in bacterial uptake by
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Figure 1. Limited activation of Langerhans cells (LCs) by bacteria results in impaired activation of bacteria-specific T cells. (a) Proliferation of naive CD4þ
T cells cocultured with S. aureus-loaded in vitro–generated dermal dendritic cells (DDCs) and LCs. The mean ±SD of four independent experiments is shown
(*Po0.05; **Po0.01). (b) Representative graphs (n¼ 5) for the proliferation of naive CD4þ T cells after coculture with S. aureus-loaded DDCs and
LCs in the absence or presence of IL-1b/TNF-a (MF). (c) CD127 and intracellular Foxp3 staining on T cells primed with S. aureus-loaded DDCs or LCs in the
absence and presence MF. Data are representative for three independent experiments. (d) The proliferation of activated bystander CD4þ T cells (target cells)
in the presence of T cells induced by S. aureus– or S. aureus/MF–primed DDCs or LCs. The proliferation of target T cells in the presence of T cells stimulated
with S. aureus/MF–DCs was set at 100%. Data show the mean ±SD of three independent experiments (**Po0.01). (e) Percentage of Foxp3þ CD4þ
T cells induced by S. aureus-loaded LCs in the absence (solvent control DMSO) or presence of SMAD3 inhibitor (representative for three independent
experiments). (f, g) The proliferation of bacteria-specific memory CD4þ T cells upon activation by S. aureus-loaded DDCs and LCs. Data show the
mean±SD of four independent experiments (**Po0.01).
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LCs and DDCs can be attributed to different expression levels
of CD32.
LCs have a low expression of molecules involved in MHC-II
processing and presentation and are inefficient at processing
bacterial Ags
To determine to what extent the inefficient bacterial uptake by
LCs contributed to low activation of bacteria-specific T cells,
we selected LCs and DDCs with equal bacterial load and
compared their capacity to activate Ag-specific CD4þ T cells.
Strikingly, although the differences between LCs and DDCs
became smaller, the ability to stimulate bacteria-specific T-cell
proliferation was still significantly lower for LCs (Figure 4a),
showing that the limited internalization capacity of LCs is
partly responsible for the low efficiency to activate bacteria-
specific T cells. Efficient Ag presentation by DCs also depends
on effective degradation of internalized bacterial cargo in
endosomal compartments. We analyzed phagosome matura-
tion by CLSM and immuno-EM and found that S. aureus
initially colocalized with EEA-1þ early endosomes and that in
both LCs and DDCs, these bacteria-containing early endo-
somes matured into late endosomes/lysosomes, as indicated
by the acquirement of late endosomal/lysosomal markers
LAMP-1 and HLA-DM (Figure 4b). However, the number of
bacteria colocalizing with LAMP was much less in LCs than in
DDCs. Moreover, immuno-EM also revealed that CD63 acqui-
sition of phagosomes was evidently less in LCs than in DDCs
(arrows, Figure 4c). Quantification of colocalization of S. aureus
with EEA-1þ and LAMPþ endosomes by multispectral imaging
FACS (Supplementary Figure S4 online) demonstrated that the
percentage of internalized bacteria that colocalized with LAMP
was twice as low in LCs compared with DDCs, and in LCs a
high percentage of the internalized bacteria still colocalized
with EEA-1 (Figure 4d). Collectively, these data indicate that
after bacterial uptake, phagosome maturation into late endoso-
mal/lysosomal compartments is slower in LCs than in DDCs.
The capacity of LCs to present bacterial Ags is not enhanced by
TLR signaling
Phagosome maturation and the capacity to present Ags
through the MHC-II pathway have been linked to TLR trigger-
ing by the internalized material (Blander and Medzhitov,
2006). As LCs do not express bacterial sensors TLR2, TLR4,
and TLR5, we examined whether the inefficient presentation
of bacterial Ags by LCs could be overcome by triggering TLR
signaling pathways TRIF and MyD88 in an alternative manner,
using TLR3 and TLR7, respectively, as LCs express these TLRs.
LCs also express TLR1 and TLR6, but triggering through these
TLRs would not be appropriate, as both TLR1 and TLR6 have
to form a heterodimer with TLR2 to become functional, and
LCs lack TLR2. The addition of TLR3 or TLR7 ligand during
bacterial uptake only slightly enhanced bacterial uptake
(Figure 5a) and did not affect their induction of bacteria-
specific T-cell proliferation (Figure 5b). To address the possi-
bility that TLR signaling must be triggered specifically at the
site of phagosome formation, that is, involving local cell
surface TLRs, we generated TLR2þ LCs using mRNA transfec-
tion. These transfected LCs responded to TLR2-ligand
Pam3CSK by producing comparable levels of IL-6 as DDCs
(Supplementary Figure S5 online) showing functionality of the
ectopically expressed TLR2. However, the TLR2 expression by
LCs did neither enhance the capacity to internalize bacteria
(Figure 5c) nor the capacity to induce T-cell proliferation
(Figure 5d), showing that the low efficiency of LCs to present
bacterial Ags is not because of the absence of TLRs that
recognize bacteria.
LCs have a low expression of molecules involved in MHC-II
processing and presentation
The observation that phagosomal maturation is slower in
LCs than in DDCs indicates that LCs differ in their capacity
to process Ags and to load Ags onto MHC-II molecules.
Microarray analysis revealed a markedly low expression of
many genes encoding proteins that are associated with
Ag processing in the MHC-II pathway by LCs (Figure 6a).
LCs also showed low expression of genes involved in the
regulation of Ag loading onto MHC-II molecules such as HLA-
DM and HLA-DO. No significant differences were found in
mRNA expression of Ii and master transcriptional regulator of
class II genes CIITA. These findings were confirmed by
quantitative PCR and FACS on skin-derived and in vitro–
generated LCs and DDCs (Supplementary Figure S6a–c
online). The higher expression of RAB14 in LCs (Figure 6a)
is interesting, as this small GTPase attenuates the fusion of
phagosomes with lysosomes (Kyei et al., 2006) and
consequently may contribute to the low Ag processing in
LCs. Although not significant, we found in LCs a higher
expression of MARCH1, which negatively regulates Ag
presentation by ubiquitinating MHC class II and reducing its
surface expression. (de Gassart et al., 2008).
Incubation with OVA bound to a self-quenched fluoro-
chrome confirmed that LCs are considerably less efficient
compared with DDCs in processing Ags, as indicated by the
release of fluorescent decomposition products (Figure 6b). To
investigate whether LCs and DDCs show a differential capa-
city for MHC-II Ag loading, we compared their efficacy to
exchange CLIP for antigenic peptides upon incubation with
S. aureus. For this, we analyzed the relative expression of stable
MHC-II/Ag complexes using mAb 16.23, specifically recog-
nizing HLA-DR3/Ag complexes (Johnson et al., 1982) and the
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mAb CerCLIP.1 that recognizes MHC-II/CLIP complexes.
FACS showed that S. aureus DDCs upregulated not only
total HLA-DR but also the fraction of stable HLA-DR3/Ag
complexes with a decrease in the relative expression of HLA-
DR/CLIP. In contrast, incubation of LCs with S. aureus
stimulated MHC-II export to some extent, but the amount of
HLA-DR3/Ag complexes did not increase (Figure 6c). This
indicates that the increase of MHC-II export to the plasma
membrane is accompanied by efficient exchange of CLIP for
antigenic peptides in DDCs and not in LCs. These observa-
tions are in line with the low expression of HLA-DM in LCs. In
summary, these data demonstrate that LCs are less efficient
compared with DDCs in Ag processing and Ag loading onto
MHC-II molecules.
LC
DDC LC
None – Fc block Fc block
0
20
40
60
+HS +Ig
*
*
*
**
** *
** DDC
LC
+HS
+HS
+HS
+HS
None
None
Iso
Iso
Iso
Iso
αCD32
+HS
+HS DDC
LC
20100 30 40 50
None
Iso
Iso
αCD32
αCD16
αCD64
None
αCD32
None
None
αCD32
αCD32
20 30 40 5010
20 30 40 50100
CD32CD16 CD32
*
**
**
*
**
**
100
80
60
%
 o
f m
ax
40
20
0
100
80
60
%
 o
f m
ax
40
20
0
100
80
60
%
 o
f m
ax
40
20
0
100
80
60
%
 o
f m
ax
40
20
0
100
80
60
%
 o
f m
ax
40
20
0
100
80
60
%
 o
f m
ax
40
20
0
0102 103 104 105 0102 103 104 105 0102 103 104 105 0102 103 104 105 0102 103 104 105 0102 103 104 105
CD64 CD16 CD64
Skin-DDC Skin-LC
DDC
Pe
rc
en
ta
ge
 w
ith
 b
ac
te
ria
S. aureus 
E. coli 
Skin-DDC
Skin-LC
Percentage with bacteria
Percentage with bacteria
αCD16
αCD32
αCD64
Figure 3. Low bacterial uptake of Langerhans cells (LCs) is attributed to low FccRIIa expression. (a) Representative electron microscopy (EM) picture of dermal
dendritic cells (DDCs) and LCs during internalization of S. aureus. (b) FACS analysis of uptake of S. aureus–GFP by in vitro–generated DDCs and LCs after
opsonization with HS or purified human Ig in the absence ( ) or presence of antibodies for blocking total FcR. (c) Uptake of S. aureus or E. coli by skin-derived
DDCs and LCs in the absence (none) or presence of HS and blocking CD32 antibodies or IgG2b isotype control (iso). (d) Uptake of S. aureus by in vitro–generated
DDCs and LCs in the absence (none) or presence of HS and blocking CD16, CD32, CD64 antibodies, or IgG1 and IgG2b isotype control antibodies (iso).
(e) CD16, CD32, and CD64 expression on skin-derived DDCs and LCs or (f) in vitro–generated DDCs and LCs. Data show one representative (a, e, f) or the
mean±SD from three independent experiments (b–d, *Po0.05; **Po0.01).
AMG van der Aar et al.
Impaired Induction of Antibacterial Immunity by LCs
1244 Journal of Investigative Dermatology (2013), Volume 133
EEA-1 LAMP-1
0
10
20
30
40
DDC
LC
0
5
10
15
20
25
30
35
**
**
**
*
**
* *
DDC
LC1
LC2
LC
DDC
DDC
LC
3 H
-T
dR
 (c
.p.
m.
 ×1
03
)
10,000 3,000 1,000 300
Number of DCs
Co
lo
ca
liz
at
io
n 
(%
)
EEA1 (30′) HLA-DM (120′) LAMP-1 (120′)
Sa
Sa
Figure 4. Langerhans cells (LCs) are inefficient in processing bacterial antigens. (a) Dermal dendritic cells (DDCs) and LCs with normal bacterial load
(LC1) and LCs with an equal bacterial load as the DDCs (LC2, selected by FACS) were cocultured with 40,000 bacteria-specific CD4þ T cells. T-cell proliferation
was measured by [3H]-thymidine incorporation. Data show the mean ±SD of four independent experiments (*Po0.05; **Po0.01). (b) DC subsets were
incubated for 0.5–2 hours with S. aureus–GFP and subsequently stained for endosomal markers. Colocalization of bacteria with endosomes was analyzed by
confocal laser scanning microscopy. Figures show representative serial Z-stack images for colocalization of bacteria in DDCs and LCs with Early Endosome
Antigen 1 protein (EEA-1) (30 minutes), HLA-DM (120 minutes), and lysosomal-associated membrane protein 1 (LAMP-1) (120 minutes). Colocalization
appears yellow, and insets show boxed areas with enlarged colocalization and correlating bright-field images. (c) Analysis of internalization of S. aureus after
2 hours by immuno-EM. Arrows indicate one representative bacteria-containing phagosome stained with CD63-gold immuno-label. (d) Quantification of
colocalization of bacteria with EEA-1 and LAMP-1 by multispectral imaging FACS 1.5 hours after incubation. The amount of bacteria colocalizing with
EEA-1þ or LAMP-1þ endosomes was calculated as a percentage of the total amount of internalized bacteria. Data are representative of three independent
experiments.
AMG van der Aar et al.
Impaired Induction of Antibacterial Immunity by LCs
www.jidonline.org 1245
DISCUSSION
This study unequivocally shows that internalization, degrada-
tion, and MHC-II loading of bacterial Ags are functions that
are poorly performed by LCs, resulting in a low activation of
bacteria-specific T cells. A low capacity to internalize bacteria
by LCs is supported by a study showing that only a minority
of freshly isolated human LCs internalized Gram-negative
Borrelia burgdorferi, whereas freshly isolated DDCs eagerly
internalized these bacteria (Filgueira et al., 1996). Here, we
show impaired internalization of not only Gram-negative
E. coli but also Gram-positive bacteria S. aureus.
The low capacity of LCs to internalize and process bacteria
was attributed to several intrinsic properties, such as impaired
FcgR expression and low expression of molecules related to
the MHC-II-processing machinery. The low expression of
MHC-II-processing-related genes by LCs is in line with a
previous report (Klechevsky et al., 2009), which did not
address functional consequences. Highly purified, freshly
isolated authentic human epidermal LCs selectively lack
bacterial sensors TLR2, TLR4, and TLR5 rendering these cells
unable to respond efficiently to bacteria (van der Aar et al.,
2007). However, some reports show responsiveness of LCs to
TLR2 and TLR4 agonists (Peiser et al., 2008; Aliahmadi et al.,
2009; Duraisingham et al., 2009; Jurkin et al., 2010; Pen˜a-
Cruz et al., 2010). These contradictory observations may be
explained by differences in laboratory protocols, purity of the
LCs, or LC-model used (CD34 stem cell–derived, monocyte-
derived, or epidermis crawl-out matured LCs), providing LC
populations with variant TLR profiles and responsiveness to
TLR triggering, not resembling those of bona fide epidermis-
derived immature LCs. Although a link between adequate TLR
triggering and efficiency to process and present Ags has
previously been reported (Blander and Medzhitov, 2006), the
limited uptake of bacteria and Ag presentation by LCs could
not be enhanced by introducing functional TLR2 triggering. As
a consequence of the limited presentation of bacterial Ags, LCs
not only have a limited capacity to activate naive T cells but
also, in contrast to DDCs, provoke weak reactivation of
memory CD4þ T cells, which do not require high levels of
costimulation. In addition, the presence of inflammatory cyto-
kines IL-1b and TNF-a could not enhance the stimulation of
bacteria-specific memory T cells, suggesting that in situ LCs
are not easily provoked by activated surrounding keratinocytes
to induce antibacterial T-cell immunity.
Interestingly, bacteria-primed LCs, and not bacteria-primed
DDCs, induced a high percentage of bacteria-specific Foxp3þ
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Figure 5. The capacity of Langerhans cells (LCs) to present bacterial antigens is not enhanced by Toll-like receptor (TLR) signaling. (a) Internalization of
S. aureus–GFP by in vitro–generated dermal dendritic cells (DDCs) and LCs 1 hour after coincubation in the absence or presence of TLR ligands R848 or
p(I:C), showing the mean fluorescence intensity (MFI) as measurement of the numbers of internalized bacteria by LCs and DDCs. (b) The proliferation of
bacteria-specific CD4þ T cells after incubation with DDCs and LCs loaded with S. aureus in the absence or presence of R848 or p(I:C). (c) Internalization of
S. aureus and (d) induction of bacteria-specific CD4þ T-cell proliferation by DDCs, and untreated ( ), mock-treated, or TLR2þ LCs. Data in a, b, and (c, d) are
the mean±SD of three, four, and five independent experiments, respectively.
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T cells, enforcing the concept that LCs have a role in
maintaining tolerance to the bacterial skin flora (Campbell
and Ziegler, 2007; Vignali et al., 2008). Indeed, suboptimal
DC activation (Hawiger et al., 2001; Menges et al., 2002;
Steinman et al., 2003) and very low doses of Ags (Turner et al.,
2009), or a combination of these factors (Kretschmer et al.,
2005), have previously been linked to the induction of
Tregs. Addition of inflammatory cytokines that induce matu-
ration of LCs abrogated the development of Foxp3þ T cells,
underscoring the concept that immature or semimature
DCs can induce Ag-specific tolerance. This combination of
lack of costimulation and inflammatory cytokines, due to the
selective absence of cell surface TLRs, and the inefficient
presentation of bacterial Ags by LCs appears deliberately
aimed to prevent them from activating antibacterial effector
T cells and renders them prone to induce bacteria-specific
Tregs.
Considering that epidermal LCs are the only DC subset in
the outermost layer of our body and that they are the first
immune cells to sense danger of invading pathogens, our
results may be quite unexpected. However, the limited
capacity of LCs to induce potent antibacterial T-cell immunity
may prevent harmful adaptive immune responses to the
commensal skin flora. We propose that the epidermis is a site
of immune tolerance to accommodate symbiotic interaction
with commensal bacteria, whereas bacteria penetrating the
dermal layer will readily activate DDCs. In line with our
concept, keratinocytes, the major constituent of the epidermis,
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need very high amounts of bacterial compounds to become
activated (Lebre et al., 2007).
TGF-b seems to have a dominant regulatory role in the
maintenance of tolerance to the microbial skin flora. This
cytokine is locally produced in the normal epidermis and
critically determines the functional properties of LCs, includ-
ing their selective TLR expression (Borkowski et al., 1996;
Thomas et al., 2001; van der Aar et al., 2007). In addition, this
study shows that low bacterial uptake capacity and expression
of molecules involved in the MHC-II Ag processing and
presentation pathway, which all underlie LCs’ inefficiency in
mounting antibacterial T-cell responses, are under the
influence of TGF-b. Furthermore, TGF-b is a key cytokine
for the induction of Foxp3þ Tregs (Vignali et al., 2008).
Indeed, induction of Foxp3þ Tregs was abrogated by an
inhibitor of SMAD3, supporting a role for LC-derived TGF-b.
The in vivo relevance of the induction of Tregs by LCs to
maintain tolerance for the microbial skin flora remains
to be established. In other environments that are in close
contact with commensal microbes, DCs are also important in
maintaining tolerance by inducing Tregs. For example, in the
gut, CD103þ DCs use endogenous TGF-b and retinoic acid to
induce Foxp3þ Tregs (Coombes et al., 2007). Moreover,
Allam et al. (2008) reported that oral mucosal LCs, which in
contrast to epidermal LCs do express TLR4, induce Foxp3þ
T cells in response to TLR4 ligation, by upregulating TGF-b
and IL-10, which may be important for maintaining tolerance
for the oral microbial flora.
In conclusion, this study presents evidence that DDCs
are the main Ag-presenting cells in the skin for anti-
bacterial immune responses and that LCs, to maintain a state
of tolerance for the commensal skin flora, are adapted to
avoid harmful constant induction and reactivation of antibac-
terial T cells.
MATERIALS AND METHODS
Preparation of LCs and DDCs
LCs and DDCs were generated from monocytes or purified from
human skin as described (van der Aar et al., 2007). Donation of skin
by healthy controls followed approval by the ethical committee of the
Academic Medical Center (Amsterdam, The Netherlands). This study
was conducted according to the Declaration of Helsinki and subjects
gave written informed consent. LCs were electroporated on d7 with
mRNA as described (Michiels et al., 2005).
FACS
Analysis performed as described (de Jong et al., 2002) using aMHC-II-
PERCP, aHLA-DM-PE, aLAMP-1-APC, aEEA-1, aCLIP-FITC, aCD86-
APC, and aCD83-PE (BD Biosciences, San Diego, CA), aCD16-FITC,
aCD64 (Sanquin Research, Amsterdam, The Netherlands), aCD32-PE
(Immunotech, Marseille, France), aDR3b mAb 16.23 (Johnson et al.,
1982), GaM-Alexa-405 (Molecular Probes, Invitrogen, Karlsruhe,
Germany), GaM-PE and GaM-Cy3 (both Jackson Immunoresearch
Laboratories, West Groove, PA).
Internalization and processing assays
DCs were cocultured with GFP-expressing S. aureus RN4220 and
E. coli strain DH5a (Rooijakkers et al., 2005) (five bacteria per cell
unless stated otherwise) in IMDM (Life Technologies, Paisley, UK)
containing 5% human serum (BioWhittaker, Walkersville, MD).
Uptake was stopped by cold phosphate-buffered saline and
analyzed by FACS. Antibodies against LTA (QED Bioscience, San
Diego, CA) or E. coli (AbD Serotec, Kidlington, UK) were used to
detect extracellular bacteria. When indicated, bacteria were
preincubated for 30 minutes with human Ig (IVIG, Sanquin), FcR
block (Miltenyi Biotec, Bergisch Gladbach, Germany), blocking
antibodies (10mg ml 1) against CD16 (3G8, BD), CD32 (IV.3,
Stemcell Technologies, Grenoble, France), or CD64 (10.1, BD), or
with isotype controls IgG1 (MOPC-21, BD) or IgG2b (GL198,
Sanquin), Mannan (500mg ml 1), Cytochalasin D, MDC (50mM),
and nystatin (2.5–10mM, Sigma-Aldrich, St Louis, MO). For TLR
triggering p(I:C) (Sigma-Aldrich) and R848 (InvivoGen, San Diego,
CA) were used. For CLSM, DCs were stained with aLAMP-1-Alexa-
647 (Biolegend, San Diego, CA), aEEA-1, aHLA-DM, and aCD11c
(BD Pharmingen, San Diego, CA). Quantitative analyses of
colocalization with endosomes were performed by multispectral
imaging FACS with the ImageStream system (Amnis Corporation,
Seattle, WA) using the ratio of overlapping GFP and EEA-1þ and
LAMP-1þ spots to the total number of GFP spots. To investigate Ag
processing, DCs were incubated for 1 hour with self-quenching DQ-
OVA (Molecular Probes). Digested fragments were measured using a
red-light filter. EM was performed as described previously (Calafat
et al., 1997). Sections were incubated with aCD63 (Sanquin)
followed by RaM antibody.
T-cell stimulation
DCs were incubated with bacteria (16 hours) in the absence
or presence of IL-1b (25 ng ml 1) and TNF-a (50 ng ml 1) (PBH)
or in the absence or presence of SMAD3 inhibitor (Sigma) or
solvent control DMSO and cocultured with autologous CD45RAþ
CD45RO naive CD4þ T cells as described previously
(de Jong et al., 2002) or with autologous pathogen-specific T-cell
lines (40 104). T-cell proliferation was measured by [3H]-
thymindine incorporation after 24, 48, or 72 hours. Simultaneously,
proliferating T cells were FACS-sorted on day 5 and cultured
in the presence of IL-2. Resting T cells were analyzed for
CD127 (BD Pharmingen), intracellular Foxp3, and suppressive
capacity as described previously (van der Aar et al., 2011).
Bacteria-specific T-cell lines were prepared as described (Kalinski
et al., 2003).
Quantitative PCR and microarray analysis
Gene expression of HLA-DRA, HLA-DMB, HLA-DOA, HLA-DOB,
and CIITA was measured as described (Souwer et al., 2009). Other
primers used were: Ii (50-CACCTGCTCCAGAATGCTG-30, 50-CAGTT
CCAGTGACTCTTTCG-30, 210 bp). Microarray was performed as
described (Vroling et al., 2008).
Statistics
Student t-tests were performed for paired measurements with Graph-
Pad (version 4.00; GraphPad InStat, San Diego, CA). P-values o0.05
were considered significant.
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